Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lindy Biosciences

http://www.lindybio.com

Latest From Lindy Biosciences

Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery.

Biologics Commercial

Honey, I Shrunk The Drugs: Novartis, Lindy Partner On Biologics Delivery

Novartis is paying Lindy potentially more than $900m to use its technology for making intravenous biologics available for subcutaneous injection using autoinjectors.

Drug Delivery Technology Biologics
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register